BPH Energy Ltd. (BPH)
ASX ASX Primary Summary
BPH Energy Ltd. Dividends
BPH Energy Ltd. Earnings
| 25 Aug 2025 (74 Days) Date | | - Cons. EPS | - EPS |
| 26 Feb 2025 Date | | - Cons. EPS | - EPS |
| 29 Nov 2024 Date | | - Cons. EPS | - EPS |
| 30 Oct 2024 Date | | - Cons. EPS | - EPS |
| 27 Aug 2024 Date | | - Cons. EPS | - EPS |
| 25 Aug 2025 (74 Days) Date | | - Cons. EPS | - EPS |
| 26 Feb 2025 Date | | - Cons. EPS | - EPS |
| 29 Nov 2024 Date | | - Cons. EPS | - EPS |
| 30 Oct 2024 Date | | - Cons. EPS | - EPS |
| 27 Aug 2024 Date | | - Cons. EPS | - EPS |
BPH Energy Ltd. (BPH) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has BPH Energy Ltd. ever had a stock split?
BPH Energy Ltd. Profile
| Asset Management Industry | Financial Services Sector | Mr. David Leslie Breeze CEO | ASX Exchange | AU000000BPH4 ISIN |
| Australia Country | - Employees | - Last Dividend | 30 Mar 2020 Last Split | - IPO Date |
Overview
BPH Energy Limited is a diverse investment company with a focus on the biotechnology, oil and gas exploration and development, and medicinal cannabis industries within Australia. The company, originally known as BioPharmica Limited, transitioned to BPH Energy Limited following its incorporation in 2001. Its operations span several innovative projects, including the development of clean hydrogen and conductive carbon production systems for battery manufacturing and investments in groundbreaking biomedical research. BPH Energy Limited is based in Stirling, Australia, and maintains a portfolio that reflects its commitment to contributing to various sectors with significant implications for health, energy, and environmental sustainability.
Products and Services
- Clean Hydrogen and Conductive Carbon Production
BPH Energy Limited is at the forefront of developing a system intended for the generation of clean hydrogen and conductive carbon, with the ultimate goal of providing materials for commercial battery manufacturing. This initiative highlights the company's commitment to sustainable energy solutions and its contribution to the evolving energy storage market.
- Brain Anaesthesia Response Monitoring System
The company offers a sophisticated device designed to monitor the effects of anaesthetic agents on brain activity, thereby assisting anaesthetists in maintaining optimal levels of anaesthesia during surgeries. This technology underscores BPH Energy Limited's dedication to improving patient care and surgical outcomes through innovation.
- Biomedical Research into HLS5 Tumour Suppressor Gene
In the critical field of cancer research, BPH Energy Limited has invested in the study of the HLS5 tumour suppressor gene, specifically targeting liver cancer. This research represents a vital component of the company's biotechnology endeavors, aiming at uncovering novel therapeutic strategies against cancer.
- Oil and Gas Exploration and Development
Holding a 100% interest in the RL1 oil and gas assets within the onshore Bonaparte basin in northern Australia, along with an 85% interest in the petroleum exploration permit 11 in the offshore Sydney basin, BPH Energy Limited is actively involved in the exploration and development of vital energy resources. These activities signify the company's strategic investment in the energy sector, potentially contributing to Australia's energy security and economic growth.
Contact Information
